IFARS Pharmaceutical Laboratories
IFARS Pharmaceutical Laboratories is an Indonesian manufacturer of semi-solid pharmaceuticals and antibiotics, founded in 1974 and headquartered in Solo, serving the domestic healthcare market with a workforce of 501-1,000 employees.
- Company typePrivate
- Founded1974
- HeadquartersSolo, Indonesia
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What IFARS Pharmaceutical Laboratories does
IFARS Pharmaceutical Laboratories is an Indonesian for-profit pharmaceutical manufacturer founded in 1974 and headquartered in Solo, Indonesia. The company manufactures semi-solid pharmaceuticals and antibiotics, operating within Indonesia's BPOM-regulated pharmaceutical manufacturing sector. With a workforce of 501-1,000 employees, IFARS is positioned as a mid-sized domestic pharmaceutical producer with five decades of continuous operating history.
The company's product focus on semi-solid dosage forms (creams, ointments, gels) and antibiotics suggests a generic pharmaceutical portfolio targeting both prescription and over-the-counter channels in the Indonesian domestic market. Manufacturing operations are based in Solo, Central Java, a regional industrial hub. The company's digital infrastructure is limited — its primary web presence at ifars.co.id currently displays only a loading/verification screen with no product catalog, pricing, distribution information, or corporate disclosures accessible to external observers, which constrains any deeper analysis of product mix, customer base, or operational scale beyond the firmographic profile.
Business model mechanics cannot be specified from the supplied data: no pricing model, distribution channel detail, customer segmentation, or revenue structure is disclosed. As a private Indonesian pharmaceutical manufacturer of its vintage and size, the implied operating model is B2B sales to domestic wholesalers, hospitals, pharmacies, and government procurement channels, but this remains inferred rather than documented. No recent funding events, leadership changes, product launches, partnership announcements, or strategic actions have been disclosed in the input data, and no financial filings or revenue figures have been shared.
IFARS Pharmaceutical Laboratories firmographics
Firmographics- Name
- IFARS Pharmaceutical Laboratories
- Website
- https://ifars.co.id
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IFARS Pharmaceutical Laboratories is an Indonesian manufacturer of semi-solid pharmaceuticals and antibiotics, founded in 1974 and headquartered in Solo, serving the domestic healthcare market with a workforce of 501-1,000 employees.
- Ownership category
- akta.pro rank
IFARS Pharmaceutical Laboratories industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where IFARS Pharmaceutical Laboratories is headquartered
LocationHeadquarters
- HQ city
- Solo
- HQ country
- Indonesia
- HQ region
- Asia
Markets served
IFARS Pharmaceutical Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
IFARS Pharmaceutical Laboratories product offering
Product offeringCore offering
IFARS Pharmaceutical Laboratories manufactures semi-solid pharmaceutical products and antibiotics, focusing on medicine production. The company operates a pharmaceutical laboratory engaged in producing essential medicinal formulations for distribution within Indonesia.
Product overview
No product or service information available from the provided source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Semi-solid Pharmaceuticals
- Antibiotics
Companies that use IFARS Pharmaceutical Laboratories
Customer profileIdeal customer profiles1 record
IFARS Pharmaceutical Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IFARS Pharmaceutical Laboratories competitors and assessment
Company assessmentMarket position
Competitive moat3 records
Key highlights4 records
Customer concentration
IFARS Pharmaceutical Laboratories social profiles
Digital presenceIFARS Pharmaceutical Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
IFARS Pharmaceutical Laboratories leadership team
Management profileNumber of profiles
IFARS Pharmaceutical Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IFARS Pharmaceutical Laboratories M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IFARS Pharmaceutical Laboratories
What does IFARS Pharmaceutical Laboratories do?
IFARS Pharmaceutical Laboratories manufactures semi-solid pharmaceutical products and antibiotics, focusing on medicine production. The company operates a pharmaceutical laboratory engaged in producing essential medicinal formulations for distribution within Indonesia.
Is IFARS Pharmaceutical Laboratories a public or private company?
IFARS Pharmaceutical Laboratories is a private company. It is classified as unknown and is currently operating.
When was IFARS Pharmaceutical Laboratories founded?
IFARS Pharmaceutical Laboratories was founded in 1974. It employs 101 to 250 people.
Where is IFARS Pharmaceutical Laboratories based?
IFARS Pharmaceutical Laboratories is headquartered in Solo, Indonesia, in the Asia region.
Does IFARS Pharmaceutical Laboratories have an API?
No public API is recorded for IFARS Pharmaceutical Laboratories.
What industry is IFARS Pharmaceutical Laboratories in?
IFARS Pharmaceutical Laboratories's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.